Creating antibodies to fight henipaviruses

Development of broadly neutralizing human monoclonal antibodies against henipaviruses

['FUNDING_R01'] · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · NIH-11130131

This study is working on creating special antibodies that can fight off henipaviruses, which can make people and animals very sick, with the hope that these antibodies could help in making better vaccines in the future.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (nih funded)
Locations1 site (NEW YORK, UNITED STATES)
Trial IDNIH-11130131 on ClinicalTrials.gov

What this research studies

This research focuses on developing human monoclonal antibodies that can neutralize henipaviruses, which are known to cause severe respiratory and neurological diseases in humans and animals. The project aims to create broadly neutralizing antibodies that are effective against a wide range of henipaviruses, including Hendra and Nipah viruses, by targeting specific proteins involved in the virus's ability to infect cells. The researchers will use genetically modified mice to produce these antibodies and assess their potential for future vaccine development.

Who could benefit from this research

Good fit: Ideal candidates for this research would include individuals at high risk of exposure to henipaviruses, such as healthcare workers or those living in endemic areas.

Not a fit: Patients who are not at risk of henipavirus infections or those with existing immunity to these viruses may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to effective treatments or preventive measures against henipavirus infections, significantly reducing the risk of severe disease and death.

How similar studies have performed: Previous research has shown promise in developing monoclonal antibodies against other viral pathogens, suggesting that this approach could be effective for henipaviruses as well.

Where this research is happening

NEW YORK, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.